HORMONAL BLOCKADE FOR SALVAGE TREATMENT OF PSA ONLY RECURRENT PROSTATE CANCER AFTER INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER : MEDIAN 5 YEAR FOLLOW-UP IN 25 PATIENTS

被引：0
|
作者：
White, M. [1 ]
Mark, R. [2 ]
Anderson, P. [2 ]
Akins, R. [2 ]
Nair, M. [2 ]
机构：
[1] Joe Arrington Canc & Res Ctr, Lubbock, TX USA
[2] Joe Arrington Canc & Res Ctr, Radiat Oncol, Lubbock, TX USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1197
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [1] Hormonal Blockade for Salvage Treatment of PSA Only Recurrent Prostate Cancer after Interstitial High Dose Rate (HDR) Brachytherapy for Early Stage Prostate Cancer: Median 6 Year Follow-up in 26 Patients
    White, M.
    Mark, R. J.
    Anderson, P. J.
    Akins, R. S.
    Nair, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S394 - S394
  • [2] Hormonal Blockade Salvage Treatment of PSA Only Recurrently Prostate Cancer After Interstitial High Dose Rate (HDR) Brachytherapy for Early Stage Prostate Cancer: Long-Term Follow-Up in 26 Patients
    Mark, Rufus
    Anderson, Paul
    Akins, Robin
    Nair, Murali
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 200 - 201
  • [3] ANDROGEN DEPRIVATION THERAPY (ADT) FOR SALVAGE TREATMENT OF PSA ONLY RECURRENT PROSTATE CANCER AFTER INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER : MEDIAN 6 YEAR FOLLOW-UP IN 26 PATIENTS
    Garcia, I.
    Mark, R.
    Akins, R.
    Nair, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S250 - S250
  • [4] Androgen Deprivation Therapy (ADT) for Salvage Treatment of PSA Only Recurrent Prostate Cancer After Interstitial High Dose Rate (HDR) Brachytherapy for Early Stage Prostate Cancer: Median 6 Year Follow-Up in 26 Patients
    Mark, Rufus
    Akins, Scott
    White, Marty
    Nair, Murali
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 204 - 204
  • [5] Interstitial high dose rate (HDR) brachytherapy for early stage prostate cancer
    Mark, R
    Vallabhan, G
    Akins, R
    Anderson, P
    Nair, M
    Neumann, T
    White, D
    Gurley, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S304 - S304
  • [6] Interstitial high dose rate (HDR) brachytherapy for early stage prostate cancer
    Mark, R.
    Akins, R.
    Anderson, P.
    Neumann, T.
    Nair, M.
    White, D.
    Gurley, S.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S448 - S449
  • [7] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8 Year Results in 308 Patients
    Mark, Rufus
    Anderson, Paul
    Akins, Robin
    Nair, Murali
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 201 - 201
  • [8] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8 Year Results in 312 Patients
    Mark, R. J.
    Anderson, P. J.
    Akins, R. S.
    Nair, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S147 - S147
  • [9] INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY AS MONOTHERAPY FOR EARLY STAGE PROSTATE CANCER : MEDIAN 8 YEAR RESULTS IN 310 PATIENTS
    Mark, R.
    Anderson, P.
    Akins, R.
    Nair, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S408 - S408
  • [10] INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY AS MONOTHERAPY FOR EARLY STAGE PROSTATE CANCER : MEDIAN 8 YEAR RESULTS IN 319 PATIENTS
    Mark, R.
    Akins, R.
    White, M.
    Nair, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S285 - S285
12345